
William Franklin Pendergraft MD PhD
Glomerular Disease
CEO, Integrative Medical Clinic of North Carolina
Join to View Full Profile
Integrative Medical Clinic of North Carolina5915 Farrington Road, Suite 106Chapel Hill, NC 27517
Phone+1 984-999-0902
Fax+1 984-439-2122
Dr. Pendergraft is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2010 - 2013
- University of California (San Francisco)Residency, Internal Medicine, 2008 - 2010
- University of North Carolina at Chapel Hill School of MedicineClass of 2008
Certifications & Licensure
- NC State Medical License 2013 - 2025
- MA State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) Start of enrollment: 2018 Nov 18
Publications & Presentations
PubMed
- 115 citationsPhase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.Y Atisha-Fregoso, Susan Malkiel, Kristina M. Harris, Margie Byron, Linna Ding
Arthritis & Rheumatology. 2021-01-01 - 7 citationsPublisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.Arnon Arazi, Deepak A. Rao, Celine C. Berthier, Anne Davidson, Yanyan Liu
Nature Immunology. 2019-08-13 - 492 citationsThe immune cell landscape in kidneys of patients with lupus nephritisArnon Arazi, Deepak A. Rao, Celine C. Berthier, Anne Davidson, Yanyan Liu
Nature Immunology. 2019-06-17
Journal Articles
- A Randomized, Controlled Double-Blind Study Comparing the Efficacy and Safety of Dose-Ranging Voclosporin with Placebo in Achieving Remission in Patients with Active L...Brad H Rovin, William F Pendergraft, Kidney International
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: